All terms in EFO
| Label | Id | Description |
|---|---|---|
| Abnormal number of hair whorls | HP_0010813 | [More than two clockwise hair whorls.] |
| obsolete_high anorectal malformation | Orphanet_171201 | |
| response to perphenazine | GO_0097334 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus.] |
| response to quetiapine | GO_0097335 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.] |
| cancer affecting bone of limb skeleton | MONDO_0024311 | [A cancer that involves the limb bone.] |
| response to risperidone | GO_0097336 | |
| response to ziprasidone | GO_0097337 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus.] |
| response to clozapine | GO_0097338 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.] |
| obsolete_intermediate anorectal malformation | Orphanet_171208 | |
| neuromedin U | EFO_0003266 | [Neuromedin U (or NmU) is a neuropeptide found in the brain of humans and other mammals, which has a number of diverse functions including contraction of smooth muscle, regulation of blood pressure, pain perception, appetite, bone growth, and hormone release. It was first isolated from the spinal cord in 1985, and named after its ability to cause smooth muscle contraction in the uterus.] |
| chronic pain syndrome | MONDO_0024317 | [Chronic form of disorder involving pain.] |
| Upper limb undergrowth | HP_0009824 | [Arm shortening because of underdevelopment of one or more bones of the upper extremity.] |
| Limb undergrowth | HP_0009826 | [Limb shortening because of underdevelopment of one or more bones of the extremities.] |
| osmotic diuretic | CHEBI_50504 | [Compound that increase urine volume by increasing the amount of osmotically active solute in the urine. It also increases the osmolarity of plasma.] |
| sweetening agent role | CHEBI_50505 | [Substance that sweeten food, beverages, medications, etc.] |
| neurodevelopmental disorder with hypotonia, seizures, and absent language | MONDO_0014995 | |
| hereditary spastic paraplegia 29 | MONDO_0012334 | [Autosomal dominant spastic paraplegia type 29 (SPG29) is a complex form of hereditary spastic paraplegia characterized by a spastic paraplegia presenting in adolescence, associated with the additional manifestations of sensorial hearing impairment due to auditory neuropathy and persistent vomiting due to a hiatal or paraesophageal hernia.] |
| global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies | MONDO_0014994 | |
| short stature-delayed bone age due to thyroid hormone metabolism deficiency | MONDO_0012332 | [Short stature-delayed bone age due to thyroid hormone metabolism deficiency is a rare, genetic congenital hypothyroidism disorder characterized by mild global developmental delay in childhood, short stature, delayed bone age, and abnormal thyroid and selenium levels in serum (high total and free T4 concentrations, low T3, high reverse T3, normal to high TSH, decreased selenium). Intellectual disability, primary infertility, hypotonia, muscle weakness, and impaired hearing have also been reported.] |
| myofibrillar myopathy 8 | MONDO_0014993 | [Any myofibrillar myopathy in which the cause of the disease is a mutation in the PYROXD1 gene.] |